Kalaris Therapeutics Inc. (KLRS)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 12,948,081 | $74,710,427 | 7.26% | |
| 2. | Paradigm Biocapital Advisors Senai Asefaw | 700,000 | $4,039,000 | 0.08% | |
| 3. | Alyeska Investment Group Anand Parekh | 572,687 | $3,274,750 | +42% | 0.01% |
| 4. | Siren L.L.C. Raymond Debbane | 435,798 | $2,514,554 | 0.07% | |
| 5. | Ikarian Capital Neil Shahrestani | 360,000 | $2,077,200 | 0.17% |
Hedge Fund Resource Center